Electromed, Inc.

NYSEAM:ELMD Stock Report

Market Cap: US$200.8m

Electromed Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Jim Cunniff

Chief executive officer

US$1.5m

Total compensation

CEO salary percentage34.93%
CEO tenure2.6yrs
CEO ownership1.8%
Management average tenureno data
Board average tenure6.5yrs

Recent management updates

Recent updates

User avatar

The Triple Down On Bronchiectasis Campaign Will Expand SmartVest Clearway's Market Reach

Diversifying beyond homecare and investing in sales efforts may drive revenue growth and improve earnings through expanded market channels and effective sales execution.

CEO Compensation Analysis

How has Jim Cunniff's remuneration changed compared to Electromed's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2025n/an/a

US$9m

Sep 30 2025n/an/a

US$8m

Jun 30 2025US$1mUS$519k

US$8m

Mar 31 2025n/an/a

US$7m

Dec 31 2024n/an/a

US$7m

Sep 30 2024n/an/a

US$6m

Jun 30 2024US$3mUS$500k

US$5m

Compensation vs Market: Jim's total compensation ($USD1.49M) is about average for companies of similar size in the US market ($USD1.47M).

Compensation vs Earnings: Jim's compensation has been consistent with company performance over the past year.


CEO

Jim Cunniff (59 yo)

2.6yrs
Tenure
US$1,486,329
Compensation

Mr. James L. Cunniff, also known as Jim, serves as the President and Chief Executive Officer at Electromed, Inc., since July 01, 2023 and serves as its Director since November 10, 2023. He is Operating Par...


Board Members

NamePositionTenureCompensationOwnership
James Cunniff
President2.3yrsUS$1.49m1.79%
$ 3.6m
Gregory Fluet
Independent Director6.5yrsUS$141.34k0.25%
$ 509.5k
Kathleen Skarvan
Chairman12.3yrsUS$158.84k0.43%
$ 864.2k
Andrew Summers
Independent Director3.6yrsUS$136.34k0.11%
$ 218.3k
Kathleen Tune
Lead Independent Director4.3yrsUS$166.84k0.18%
$ 363.9k
Andrea Walsh
Independent Director5.3yrsUS$139.34k0.22%
$ 436.7k
Stan Erickson
Independent Vice Chairman of the Board11.3yrsUS$144.34k0.47%
$ 941.7k
Joseph Galatowitsch
Independent Director4.3yrsUS$134.34k0.18%
$ 363.9k
Anne O'Donnell
Member of Bronchiectasis Advisory Board8.5yrsno datano data
Chad Marion
Member of Bronchiectasis Advisory Board8.5yrsno datano data
Peadar Noone
Member of Bronchiectasis Advisory Board8.5yrsno datano data
6.5yrs
Average Tenure
61yo
Average Age

Experienced Board: ELMD's board of directors are considered experienced (6.5 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/02/22 11:57
End of Day Share Price 2026/02/20 00:00
Earnings2025/12/31
Annual Earnings2025/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Electromed, Inc. is covered by 6 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kyle BauserB. Riley Securities, Inc.
Anderson SchockB. Riley Securities, Inc.
Ilya ZubkovFreedom Broker